Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT07055711

Association Between Work-Related Stress and Peripheral Neuropathic Pain in Female Breast Cancer Post CT

This research aims to find the association between work-related stress and peripheral neuropathic pain in female breast cancer survivors post-chemotherapy.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Key information

Age range

21 year–51 year

Sex eligibility

Female

Study type

Observational

Primary location

Lahore City

Lahore, Pakistan

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Females who have completed chemotherapy at least o1 year prior to study.
  • Aged 29-51.
  • Females who is currently employed.
  • Females who have done chemotherapy for stage 1,2,3.
  • Females who underwent chemotherapy cycles 6-8.
  • Females who are willing to participate in the study

Exclusion criteria

  • Females suffering from psychiatric conditions such as anxiety and depression.
  • Females suffering from diabetes.
  • Females who have active cancer.
  • Females with mastectomy.
  • Absent from treatment for more than 2 weeks will be excluded from the study.

Treatment and study plan

Peripheral Neuropathic Pain

Diagnostic Test

to find out the association between work-related stress and peripheral neuropathic pain in female breast cancer survivors post-chemotherapy.

Primary outcomes

  1. Douleur Neuropathique 4 (DN4) Questionnaire

    Time frame: 6 Month

    The DN4 questionnaire is used to assess the neuropathic pain, if the score is > 4 it indicates the neuropathic pain is present while <3 than is unlikely.

  2. visual analog scale

    Time frame: 6 Months

    The visual analog scale provide quantitative measurement of pain level which is from no pain to severe pain . The range of the scale is in between 0-10mm. 0-4 is consider as no pain, 5-44 is consider as mild pain,45-74 is moderate and > 75 is consider as severe pain.

Sponsors and collaborators

Lead sponsor

Superior University

Other

Registry information

Official study title

Association Between Work-Related Stress and Peripheral Neuropathic Pain in Female Breast Cancer Survivors Post-Chemotherapy

Important dates

Study start
2025
Primary completion
2025
Study completion
2025
First posted
Jul 9, 2025
Registry last updated
Jul 9, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.